Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 37017

Los Angeles, CA 90024


Study Summary:

Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine


Qualified Participants Must:

• Have had at least a 1-year history of migraine with or without aura consistent with a diagnosis according to the International Classification of Headache Disorders, 3rd edition, beta version
• Have had migraine onset before age 50
• Have a history of migraines typically lasting between 4 and 72 hours if untreated or treated unsuccessfully and migraine episodes are separated by at least 48 hours of headache pain freedom
• Have a history of 2 to 8 migraine attacks per month with moderate to severe headache pain in each of the previous 3 months


Qualified Participants May Receive:

Free medication, Free evaluations, $100.00 per visit.


Research Site Profile

View Clinic Profile


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.